0001209191-22-048720.txt : 20220906
0001209191-22-048720.hdr.sgml : 20220906
20220906161129
ACCESSION NUMBER: 0001209191-22-048720
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220901
FILED AS OF DATE: 20220906
DATE AS OF CHANGE: 20220906
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Rice David William
CENTRAL INDEX KEY: 0001932923
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-56424
FILM NUMBER: 221228381
MAIL ADDRESS:
STREET 1: C/O LIFE360, INC.
STREET 2: 539 BRYANT STREET, SUITE 402
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94107
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Life360, Inc.
CENTRAL INDEX KEY: 0001581760
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMPUTER PROCESSING & DATA PREPARATION [7374]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 539 BRYANT STREET, SUITE 402
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94107
BUSINESS PHONE: 415-462-0002
MAIL ADDRESS:
STREET 1: 539 BRYANT STREET, SUITE 402
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94107
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-09-01
0
0001581760
Life360, Inc.
360.AX
0001932923
Rice David William
C/O LIFE360, INC.
539 BRYANT STREET, SUITE 402
SAN FRANCISCO
CA
94107
0
1
0
0
Chief Operating Officer
Common Stock
2022-09-01
4
S
0
12962
9.9976
D
379870
D
This reported sale was executed on the Australian Securities Exchange (the "ASX") as Chess Depositary Interests ("CDIs") and sold using Australian Dollars. The CDIs are traded on the ASX and are held by CHESS Depositary Nominees Pty, Limited, a subsidiary of ASX Limited, the company that operates the ASX.
Represents shares of the Issuer's common stock underlying 38,886 CDIs.
Prices in this Form 4 are expressed in United States Dollars using the conversion rate on September 1, 2022. The reported sale price in Column 4 is a weighted average price. These shares were sold in multiple transactions. Prices ranged from $9.9813 to $10.0832 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Includes 317,570 shares of the Issuer's common stock underlying 952,710 CDIs. Also includes 62,300 restricted stock units, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting.
/s/ Daniel Menudier, as Attorney-in-Fact
2022-09-06